Clene(CLNN) - 2025 Q3 - Quarterly Results

Form 8-K Filing Details Registrant and General Information This section identifies CLENE INC. as the registrant, a Delaware corporation, and details the Form 8-K filing date of October 14, 2025, confirming its non-emerging growth company status - Registrant: CLENE INC., a Delaware corporation[1] - Date of Report: October 14, 2025[1] - The registrant is not an emerging growth company[5] Securities Registered This section details the classes of securities, Common Stock and Warrants, registered under Section 12(b) of the Act and traded on The Nasdaq Capital Market | Title of each class | Trading Symbol(s) | Name of each exchange on which registered | | :------------------ | :---------------- | :---------------------------------------- | | Common Stock, $0.0001 par value | CLNN | The Nasdaq Capital Market | | Warrants, to acquire one-fortieth of one share | CLNNW | The Nasdaq Capital Market | | of Common Stock for $230.00 per share | | | Current Report Items Item 2.02 Results of Operations and Financial Condition Clene Inc. released preliminary unaudited financial information on October 14, 2025, including cash and equity proceeds, emphasizing its provisional and unaudited nature - Clene Inc. released preliminary unaudited financial information on October 14, 2025, via an updated corporate presentation[6] - Financial information includes cash and cash equivalents as of September 30, 2025, and gross proceeds from the equity distribution agreement through October 14, 2025[6] - The preliminary financial information is unaudited, subject to change, and should not be unduly relied upon due to potential material variations in actual results[7] Item 7.01 Regulation FD Disclosure This item incorporates Item 2.02 information by reference, clarifying that the furnished data, including Exhibit 99.1, is not "filed" under Section 18 of the Exchange Act - Information from Item 2.02 of this Current Report on Form 8-K is incorporated by reference into this item[9] - The furnished information, including Exhibit 99.1, is not considered 'filed' under Section 18 of the Exchange Act and is exempt from its liabilities[10] Item 9.01 Financial Statements and Exhibits This section enumerates the Form 8-K exhibits, specifically the Corporate Presentation (Exhibit 99.1) and the Cover Page Interactive Data File (Exhibit 104) | Exhibit Number | Exhibit Description | | :------------- | :------------------ | | 99.1 | Corporate Presentation | | 104 | Cover Page Interactive Data File (formatted as Inline XBRL) | Signatures Report Authorization The report was duly authorized and signed by Robert Etherington, President and CEO of CLENE INC., on October 14, 2025 - The report was signed on behalf of CLENE INC. by Robert Etherington, President and Chief Executive Officer[16] - Date of signature: October 14, 2025[16]